Skip to main content

Articles

Page 124 of 143

  1. Currently, no data on the optimal time point after acute ischemic stroke (IS) at which high-sensitivity C-reactive protein (hs-CRP) level is most predictive of unfavorable outcome. We tested the hypothesis tha...

    Authors: Kuo-Ho Yeh, Tzu-Hsien Tsai, Han-Tan Chai, Steve Leu, Sheng-Ying Chung, Sarah Chua, Yung-Lung Chen, Hung-Sheng Lin, Chun-Man Yuen and Hon-Kan Yip
    Citation: Journal of Translational Medicine 2012 10:6
  2. Exosomes are released from multiple cell types, contain protein and RNA species, and have been exploited as a novel reservoir for disease biomarker discovery. They can transfer information between cells and ma...

    Authors: Jonathan M Street, Perdita E Barran, C Logan Mackay, Stefan Weidt, Craig Balmforth, Tim S Walsh, Rod TA Chalmers, David J Webb and James W Dear
    Citation: Journal of Translational Medicine 2012 10:5
  3. Oncolytic viruses refer to those that are able to eliminate malignancies by direct targeting and lysis of cancer cells, leaving non-cancerous tissues unharmed. Several oncolytic viruses including adenovirus st...

    Authors: Sandeep S Patil, Ivaylo Gentschev, Ingo Nolte, Gregory Ogilvie and Aladar A Szalay
    Citation: Journal of Translational Medicine 2012 10:3
  4. Proliferation and migration of vascular smooth muscle cells (VSMCs) play a key role in neointimal formation which leads to restenosis of vein graft in venous bypass. STAT-3 is a transcription factor associated...

    Authors: Jiangbin Sun, Jinhua Zheng, Kaitelynne H Ling, Keyan Zhao, Zhongshang Xie, Bo Li, Tiance Wang, Zhicheng Zhu, Amit N Patel, Weiping Min, Kexiang Liu and Xiufen Zheng
    Citation: Journal of Translational Medicine 2012 10:2
  5. The outcome prediction in cancer is usually achieved by evaluating tissue samples obtained during surgical removal of the primary tumor focusing on their histopathological characteristics. Tumor staging (AJCC/...

    Authors: Jérôme Galon, Franck Pagès, Francesco M Marincola, Magdalena Thurin, Giorgio Trinchieri, Bernard A Fox, Thomas F Gajewski and Paolo A Ascierto
    Citation: Journal of Translational Medicine 2012 10:1
  6. For clinical applications, dendritic cells (DCs) need to be generated using GMP-approved reagents. In this study, we tested the characteristics of DCs generated in two clinical grade culture media and activate...

    Authors: Jitka Fučíková, Daniela Rožková, Hana Ulčová, Vít Budinský, Klára Sochorová, Kateřina Pokorná, Jiřina Bartůňková and Radek Špíšek
    Citation: Journal of Translational Medicine 2011 9:223
  7. Human genome sequencing is the process by which the exact order of nucleic acid base pairs in the 24 human chromosomes is determined. Since the completion of the Human Genome Project in 2003, genomic sequencin...

    Authors: Karen K Mestan, Leonard Ilkhanoff, Samdeep Mouli and Simon Lin
    Citation: Journal of Translational Medicine 2011 9:222
  8. The treatment of human cancer has been seriously hampered for decades by resistance to chemotherapeutic drugs. Mechanisms underlying this resistance are far from being entirely known. A very efficient mechanis...

    Authors: Enrico P Spugnini, Alfonso Baldi, Sabrina Buglioni, Francesca Carocci, Giulia Milesi de Bazzichini, Gianluca Betti, Ilaria Pantaleo, Francesco Menicagli, Gennaro Citro and Stefano Fais
    Citation: Journal of Translational Medicine 2011 9:221
  9. Renal cell carcinoma (RCC) responds to agents that inhibit vascular endothelial growth factor (VEGF) pathway. Sorafenib, a multikinase inhibitor of VEGF receptor, is effective at producing tumor responses and ...

    Authors: Xiaoen Wang, Liang Zhang, S Nahum Goldberg, Manoj Bhasin, Victoria Brown, David C Alsop, Sabina Signoretti, James W Mier, Michael B Atkins and Rupal S Bhatt
    Citation: Journal of Translational Medicine 2011 9:220
  10. Degraded extracellular matrix can stimulate the innate immune system via the Toll-Like Receptor-4 (TLR4). In the pancreas, syndecan-anchored heparan sulphate (HS) on the ductal epithelium can be cleaved off it...

    Authors: Hamid Akbarshahi, Jakob BF Axelsson, Katarzyna Said, Anders Malmström, Hans Fischer and Roland Andersson
    Citation: Journal of Translational Medicine 2011 9:219
  11. In mid November the biopharma industry was shocked by the announcement from Geron that they were ending work on embryonic stem cell research and therapy. For more than 10 years the public image of all stem cel...

    Authors: Thomas Ichim, Neil H Riordan and David F Stroncek
    Citation: Journal of Translational Medicine 2011 9:218
  12. Th17 cells play a role in inflammation. Interleukin (IL)-10 is a potent anti-inflammatory cytokine. However, it is poorly understood whether and how endogenous IL-10 impacts the development of Th17 cells in hu...

    Authors: Cailin M Wilke, Lin Wang, Shuang Wei, Ilona Kryczek, Emina Huang, John Kao, Yanwei Lin, Jingyuan Fang and Weiping Zou
    Citation: Journal of Translational Medicine 2011 9:217
  13. The immune modulatory effect of granulocyte colony-stimulating factor (G-CSF) on T cells resulted in an unexpected low incidence of graft-versus-host disease (GVHD) in allogeneic peripheral blood stem cell tra...

    Authors: Li Xuan, Xiuli Wu, Yu Zhang, Zhiping Fan, Yiwen Ling, Fen Huang, Fuhua Zhang, Xiao Zhai and Qifa Liu
    Citation: Journal of Translational Medicine 2011 9:215
  14. Scientific discoveries that provide strong evidence of antitumor effects in preclinical models often encounter significant delays before being tested in patients with cancer. While some of these delays have a ...

    Authors: Bernard A Fox, Dolores J Schendel, Lisa H Butterfield, Steinar Aamdal, James P Allison, Paolo Antonio Ascierto, Michael B Atkins, Jirina Bartunkova, Lothar Bergmann, Neil Berinstein, Cristina C Bonorino, Ernest Borden, Jonathan L Bramson, Cedrik M Britten, Xuetao Cao, William E Carson…
    Citation: Journal of Translational Medicine 2011 9:214
  15. BORIS, or CTCFL, the so called Brother of the Regulator of Imprinted Sites because of the extensive homology in the central DNA binding region of the protein to the related regulator, CTCF, is expressed in ear...

    Authors: Rosalia de Necochea-Campion, Anahit Ghochikyan, Steven F Josephs, Shelly Zacharias, Erik Woods, Feridoun Karimi-Busheri, Doru T Alexandrescu, Chien-Shing Chen, Michael G Agadjanyan and Ewa Carrier
    Citation: Journal of Translational Medicine 2011 9:213
  16. HIV vaccine development must address the genetic diversity and plasticity of the virus that permits the presentation of diverse genetic forms to the immune system and subsequent escape from immune pressure. As...

    Authors: Jeffrey R Currier, Merlin L Robb, Nelson L Michael and Mary A Marovich
    Citation: Journal of Translational Medicine 2011 9:212
  17. Treatment failure for breast cancer is frequently due to lymph node metastasis and invasion to neighboring organs. The aim of the present study was to investigate invasion- and metastasis-related genes in brea...

    Authors: Jian Pan, Li-Chao Sun, Yan-Fang Tao, Zhuan Zhou, Xiao-Li Du, Liang Peng, Xing Feng, Jian Wang, Yi-Ping Li, Ling Liu, Shui-Yan Wu, Yan-Lan Zhang, Shao-Yan Hu, Wen-Li Zhao, Xue-Ming Zhu, Guo-Liang Lou…
    Citation: Journal of Translational Medicine 2011 9:211
  18. T cell receptor (TCR) reflects the status and function of T cells. We previously developed a gene melting spectral pattern (GMSP) assay, which rapidly detects clonal expansion of the T cell receptor β variable...

    Authors: Jiezuan Yang, Jianqin He, Haifeng Lu, Li Wei, Sujun Li, Baohong Wang, Hongyan Diao and Lanjuan Li
    Citation: Journal of Translational Medicine 2011 9:210
  19. Breast cancer stem cells (BCSCs) are the source of breast tumors. Compared with other cancer cells, cancer stem cells show high resistance to both chemotherapy and radiotherapy. Targeting of BCSCs is thus a po...

    Authors: Phuc V Pham, Nhan LC Phan, Nhung T Nguyen, Nhung H Truong, Thuy T Duong, Dong V Le, Kiet D Truong and Ngoc K Phan
    Citation: Journal of Translational Medicine 2011 9:209
  20. The efficacy of the CTL component of a future HIV-1 vaccine will depend on the induction of responses with the most potent antiviral activity and broad HLA class I restriction. However, current HIV vaccine des...

    Authors: Beatriz Mothe, Anuska Llano, Javier Ibarrondo, Marcus Daniels, Cristina Miranda, Jennifer Zamarreño, Vanessa Bach, Rosario Zuniga, Susana Pérez-Álvarez, Christoph T Berger, Maria C Puertas, Javier Martinez-Picado, Morgane Rolland, Marilu Farfan, James J Szinger, William H Hildebrand…
    Citation: Journal of Translational Medicine 2011 9:208
  21. The success rate of timely translation of genome-based technologies to commercially feasible products/services with applicability in health care systems is significantly low. We identified both industry and sc...

    Authors: Jonathan A Lal, Tobias Schulte in den Bäumen, Servaas A Morré and Angela Brand
    Citation: Journal of Translational Medicine 2011 9:207
  22. Astrocyte elevated gene-1 (AEG-1) is associated with tumorigenesis and progression in diverse human cancers. The present study was aimed to investigate the clinical and prognostic significance of AEG-1 in sali...

    Authors: Wen-Ting Liao, Ling Guo, Yi Zhong, Yan-Heng Wu, Jun Li and Li-Bing Song
    Citation: Journal of Translational Medicine 2011 9:205
  23. Ipilimumab, a fully human monoclonal antibody that blocks cytotoxic T-lymphocyte antigen-4, has demonstrated an improvement in overall survival in two phase III trials of patients with advanced melanoma. The p...

    Authors: Omid Hamid, Henrik Schmidt, Aviram Nissan, Laura Ridolfi, Steinar Aamdal, Johan Hansson, Michele Guida, David M Hyams, Henry Gómez, Lars Bastholt, Scott D Chasalow and David Berman
    Citation: Journal of Translational Medicine 2011 9:204
  24. The detection of insulin autoantibodies (IAA) aids in the prediction of autoimmune diabetes development. However, the long-standing, gold standard 125I-insulin radiobinding assay (RBA) has low reproducibility bet...

    Authors: Bernice Lo, Austin DE Swafford, Kimberly A Shafer-Weaver, Lawrence F Jerome, Luba Rakhlin, Douglas R Mathern, Conor A Callahan, Ping Jiang, Lucy J Davison, Helen E Stevens, Carrie L Lucas, Jill White, Reid von Borstel, John A Todd and Michael J Lenardo
    Citation: Journal of Translational Medicine 2011 9:203
  25. Authors: Helena Canhão, Ana F Mourão, Fernando Martins, Maria J Santos, Canas Silva, Joaquim Pereira, JA Pereira Silva, José Costa, Domingos Araujo, Candida Silva, Eugenia Simões, Catia Duarte, José Antonio P Silva, Fernando Pimentel, Jaime Branco and João E Fonseca
    Citation: Journal of Translational Medicine 2011 9(Suppl 2):P55

    This article is part of a Supplement: Volume 9 Supplement 2

  26. Authors: Joana Caetano-Lopes, Ana Rodrigues, Ana Lopes, Ana C Vale, Michael A Pitts-Kiefer, Bruno Vidal, Inês P Perpétuo, Jacinto Monteiro, Yrjö T Konttinen, Maria F Vaz, Ara Nazarian, Helena Canhão and João E Fonseca
    Citation: Journal of Translational Medicine 2011 9(Suppl 2):P53

    This article is part of a Supplement: Volume 9 Supplement 2

  27. Authors: Estíbaliz Ruiz-Ortiz de Arrizabaleta, Dolors Grados-Cánovas, Aina Teniente-Serra, Virginia García-López, Bibiana Quirant-Sánchez, Susana Holgado, Alejandro Olivé, Ricardo Pujol-Borrell and Eva Martínez-Cáceres
    Citation: Journal of Translational Medicine 2011 9(Suppl 2):P51

    This article is part of a Supplement: Volume 9 Supplement 2

  28. Authors: Federica Villanova, Paola Di Meglio, Susanne Heck, Margaret Inokuma, Ryan Brinkman, Esperanza Perucha, Maria Hernandez Fuentes, Graham Lord, Skip Maino and Frank O Nestle
    Citation: Journal of Translational Medicine 2011 9(Suppl 2):P18

    This article is part of a Supplement: Volume 9 Supplement 2

  29. Authors: Rafael Fenutría, Vanesa G Martinez, Victor Gil, Jordi Sintes, Ines Simôes, Jesús Merino, Ramón Merino, Manel Ramos-Casals, Chander Raman, Pablo Engel and Francisco Lozano
    Citation: Journal of Translational Medicine 2011 9(Suppl 2):O6

    This article is part of a Supplement: Volume 9 Supplement 2

  30. Authors: Aina Teniente-Serra, Laia Grau-López, María Jesús Martínez-Arconada, Marco Fernández-Sanmartín, Cristina Ramo-Tello, Ricardo Pujol-Borrell and Eva Martínez-Cáceres
    Citation: Journal of Translational Medicine 2011 9(Suppl 2):O2

    This article is part of a Supplement: Volume 9 Supplement 2

Annual Journal Metrics